Skip to content
  • Tuesday, 27 October 2026
  • 11:07 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • ESMO 2026 Data Backs First-Line Orpathys Use in NSCLC Subgroup, But Adverse Events Temper Reaction
Pharmaceutical R&D

ESMO 2026 Data Backs First-Line Orpathys Use in NSCLC Subgroup, But Adverse Events Temper Reaction

Teuku Ryan Oct 26, 2026 0

Recent clinical findings presented at the European Society for Medical Oncology (ESMO) Congress have shed new light on the therapeutic…

Read More
Laboratory Automation & Robotics

WTWH Media Rebrands to Arrowfly, Signaling Strategic Evolution in B2B Information and Events Landscape

Lana Keisha Jul 13, 2026 0

Cleveland-based WTWH Media, a prominent and diversified entity within the business-to-business (B2B) media and events sector, officially announced its corporate…

Read More
Clinical Diagnostics & Pathology

How Clinical Laboratories Can Prepare for Crisis Events Before They Happen

Reynand Amr Wu Mar 28, 2026 0

Clinical laboratories, the silent sentinels of public health, operate at the nexus of patient care and scientific precision. Yet, this…

Read More
Clinical Diagnostics & Pathology

How Clinical Laboratories Can Prepare for Crisis Events Before They Happen

Reynand Amr Wu Mar 14, 2026 0

Clinical laboratories, the bedrock of modern healthcare, operate under an inherent vulnerability: the unexpected crisis. Unlike scheduled maintenance or anticipated…

Read More
Novo Nordisk Secures FDA Approval for Awiqli, a Once-Weekly Basal Insulin for Adults with Type 2 DiabetesTubulin Identified as a Critical Molecular Safeguard Against Neurodegenerative Protein Aggregation in Alzheimer’s and Parkinson’s DiseasesMeditation and Intensive Mind-Body Practices Produce Rapid Measurable Changes in Brain Connectivity and Blood Biology According to New ResearchFDA Reverses Course, Agrees to Review Moderna’s mRNA Flu Vaccine
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ